GSK is a research based Pharma company with R&D facilities at multiple locations around the world including the UK, USA, Spain, France and China. It conducts fundamental and applied research towards new medicines across a wide range of therapeutic areas including oncology, inflammation, anti-infectives, respiratory, metabolic, cardiovascular, neuroscience, rare diseases and diseases of the developing world. Annual R&D spend is over £3.0bn and GSK currently has ca.13,000 R&D employees globally.
Staff involved in this project:
Prof. Mike Hann is director and principal scientific investigator in chemical sciences (computational and medicinal chemistry, structural biology, biophysics and FBLD). Adjunct Professor, Dept of Chemistry, Imperial College, London.